scholarly journals Peritoneal fluid changes in horses subjected to small colon distension

2011 ◽  
Vol 31 (5) ◽  
pp. 367-373 ◽  
Author(s):  
Rafael R Faleiros ◽  
Delphim G Macoris ◽  
Carlos Henrique C Saquetti ◽  
Andrea C Aita ◽  
Anderson Farias ◽  
...  

Intestinal devitalization in cases of small colon obstruction may be difficult to detect based only in clinical signs. The purpose was to serially evaluate blood and peritoneal fluid of horses subjected to small colon distension. Seventeen adult horses were allotted in three groups. In the small colon-distended group (DG, n=7) a surgically-implanted latex balloon was inflated to promote intraluminal small colon distension. In the shamoperated group (SG, n=5), the balloon was implanted but not inflated, and no surgery was done in the control group (CG, n=5). Blood and peritoneal fluid were sampled before and after (6 samples with a 30-minute interval) intestinal obstruction for cytological and biochemical analyses. No significant changes in clinical signs occurred within groups or across time during the experimental period. There were no statistical differences among SG and SG groups in hematologic and blood chemistry variables. Although total protein concentration and lactate dehydrogenase (LDH) activity in peritoneal fluid remained most of the time within reference values during the experimental period in all groups, increases from baseline values were detected in SG and DG groups. Such increases occurred earlier, progressively and with greater magnitude in the DG when compared with the SG (P<0.05). Increases from baselines values were also observed in total nucleated cells and neutrophils counts in the DG (P<0.05). In conclusion, distension of the equine small colon induced progressive subtle increases in total protein and LDH concentrations in the peritoneal fluid during the first hours. Serial evaluation of these variables in peritoneal fluid may be useful for early detection of intestinal devitalization in clinical cases of equine small colon obstruction.

2009 ◽  
Vol 28 (10) ◽  
pp. 619-630 ◽  
Author(s):  
T. Kobayashi ◽  
N. Yasutake ◽  
K. Uchida ◽  
W. Ohyama ◽  
K. Kaneko ◽  
...  

A series of safety tests were undertaken on a novel galacto-oligosaccharide (GOS) produced from lactose by a two-step enzymatic process involving Sporobolomyces singularis and Kluyveromyces lactis. Bacterial reverse mutation and chromosomal aberration tests, with or without metabolic activation, were performed. These tests showed no mutagenesis in the Ames assay or in Escherichia coli WP2uvrA, and no chromosomal aberrations in cultured fibroblast cells from Chinese hamster lungs (CHL/IU). Micronuclei were not induced in the reticulocytes of mouse peripheral blood following oral administration of GOS. In a 90-day repeated oral dose toxicity study in rats, GOS was administered at 0, 500, 1000 and 2000 mg/kg to male and female Sprague-Dawley rats. There were no GOS-related changes in clinical signs, body weight, water intake, feed intake, urinalysis, ophthalmology, haematology, blood chemistry, organ weights, gross pathology or histopathology in any of the treatment groups compared to the control group. The no observed adverse effect level (NOAEL) of GOS was at least 2000 mg/kg/day in both males and females.


Nutrients ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 2133 ◽  
Author(s):  
Rodríguez-Lara ◽  
Mesa ◽  
Aragón-Vela ◽  
Casuso ◽  
Vázquez ◽  
...  

The objective of this study was to determine the acute (one single dose), subacute (14 days), and sub-chronic (90 days) toxicity of an aqueous virgin olive oil (VOO) extract rich in hydroxytyrosol in rats. For acute/subacute toxicity, rats were divided into three groups. The control group received distilled water (n = 9), another experimental group received a single dose of 300 mg/kg (n = 3), and a third group received one dose of 2000 mg/kg (n = 4) during 14 days. The sub-chronic study included 60rats distributed in three groups (n = 20: 10 males and 10 females) receiving daily different three doses of the VOO extract in the drinking water during 90 days: (1) 100 mg/kg, (2) 300 mg/kg, and (3) 1000 mg/kg. In parallel, a fourth additional group (n = 20: 10 males and 10 females) did not receive any extract (control group). Clinical signs, body weight, functional observations of sensory and motor reactivity, hematological and biochemical analyses, and macroscopic and microscopic histopathology were evaluated. No adverse effects were observed after the administration of the different doses of the hydroxytyrosol-rich VOO extract, which suggests that the enrichment of VOO in its phenolic compound is safe, and can be used as functional foods for the treatment of chronic degenerative diseases.


2011 ◽  
Vol 56 (No. 3) ◽  
pp. 123-130 ◽  
Author(s):  
M.R. Alam ◽  
H.B. Lee ◽  
M.S. Kim ◽  
N.S. Kim

This study was performed to make a surgical model of osteoarthritis (OA) in the dog. Experimental medial patellar luxation (MPL) was surgically produced in the left stifle (index) of 24 skeletally mature mixed small breed dogs (age two to six years and weight 2.8 to 9 kg). The animals were randomly allocated in 2 groups; sham group (n = 12), where the right stifle was sham operated and control group (n = 12) with intact right stifle. Physical and radiographic examinations of both stifles were performed at 1.5 months intervals over a one-year experimental period. One dog was euthanatized every three months, and both stifles were explored, gross examination was performed and tissue samples from the articular cartilage, cranial cruciate ligament (CCL) and synovium were collected for histomorphology. The clinical signs of OA were obvious in the experimental dogs by 12 weeks of surgical induction of MPL, which was also evidenced in the histopathology of the joint tissues and electron microscopy of the articular cartilage. The radiographic changes of OA were not obvious until remarkable degenerative changes became abvious six months postoperatively. Surgically induced MPL can be a successful tool for experimental induction of OA in dogs.


2017 ◽  
Vol 65 (2) ◽  
pp. 83 ◽  
Author(s):  
H. JAHANPOUR ◽  
A. SEIDAVI ◽  
A. A. QOTBI

This study was carried out to evaluate the effects of physical feed restriction method with different intensity and duration on broiler performance. One hundred and fifty Ross-breed 308 male broiler chicks in a completely randomized design were divided into five experimental treatments. The treatments included physical limitations by 25% or 50% of recommended amount on feed of broilers in two periods of 7 or 14 days. One control group was used fed ad libitum. Each limitation’s severity level was applied in τηρεε replications of 10 birds. All experimental treatments before and after the limitation period until slaughter (day 42) were fed ad libitum. The results showed that in total period broilers under the physical limitation of feed had significantly lower feed intake than controls (P < 0.05). In this research, methods and levels of physical restriction intensity and duration of feed had no significant effect on body weight for the whole experimental period. Methods and levels of food restriction severity and duration had significant effect on feed efficiency (P < 0.05).


2018 ◽  
Vol 2 ◽  
pp. 239784731880737
Author(s):  
Satoshi Arai ◽  
Jun-ichi Minami ◽  
Masamichi Muto ◽  
Noriyuki Iwabuchi ◽  
Koji Yamauchi ◽  
...  

In this study, the safety of Bifidobacterium breve MCC1274, a probiotic bifidobacterial strain, was assessed by single-dose and 90-day repeated-dose oral toxicity studies. In the single-dose oral toxicity assay using 6000 mg/kg of B. breve MCC1274 corresponding to 8.4 × 1011 colony-forming unit (CFU)/kg, mortality and adverse effects were not observed. Furthermore, the administration of 1000 mg/kg of B. breve MCC1274 by oral gavage in saline for 90 days did not induce any signs of toxicity, such as changes in clinical signs, body weight (BW), food consumption, ophthalmoscopy, urinalysis, hematology, blood chemistry, organ weight, gross pathology, and histopathology compared to the control group given cornstarch in saline (10/sex/group). The no-observed-adverse-effect-level of B. breve MCC1274 in the 90-day repeated-dose toxicity study was greater than 1000 mg/kg corresponding to 1.3 × 1011 CFU/kg. Based on the findings of this study, the acceptable daily intake of B. breve MCC1274 was calculated to be 1.3 × 109 CFU/kg BW/day.


1996 ◽  
Vol 62 (1) ◽  
pp. 49-56 ◽  
Author(s):  
G. M. J. Horton ◽  
J. A. Baldwin ◽  
S. M. Emanuele ◽  
J. E. Wohlt ◽  
L. R. McDowell

AbstractThirty-six 5-month-old Dorset ram lambs (28·7 kg) were used to investigate the effects of fasting and transport on performance and selected blood parameters. Three treatment groups (no. = 12) were: (1) control-food and water, without transport; (2) fasting for 72 h, without transport; and (3) transport in a trailer to a nearby auction-barn, then driven 8 h/day for 3 days without food or water for a total of 72 h. Lambs were given a total mixed diet containing 163 g/kg crude protein throughout the 28-day post-transport period. Both fasted and transported lambs consumed less food than the control group during the first 7 days post treatment (P < 0·05). Water intake was similar for all treatment groups on the 1st day post transport, after which both fasted and transport lambs drank less ivater than control lambs during the following 6 days (P < 0·05). Live-weight loss after the 3-day fast and transport period and subsequent body-weight gain during the 28-day realimentation period differed across all treatment groups (P < 0·05 and P < 0·09; (1) 1% and 305 g, (2) 14·8% and 343 g, and (3) 20·0% and 390 g, respectively, though control lambs had the highest weight gains over the 32-day experimental period. Plasma urea nitrogen was lower in both fasted and transported lambs on days 6, 7 and 11 compared with control lambs (P < 0·05). Plasma glucose concentrations on days 4 and 5 were lower in transported lambs than in fasted lambs, and highest in control lambs (P < 0·05); glucose concentration levels remained lower in both fasted and transported lambs than in control lambs on days 6 and 7 (P < 0·05). Plasma cortisol concentrations were highest in transported lambs during the 3-day transport period and for 2 days immediately following transport (P < 0·05). Effects of the 72 h fast were exacerbated by auction barn activity and subsequent transport, and compensatory gains by fasted and transport lambs were incomplete within the 28-day post transport period.


1997 ◽  
Vol 11 (3) ◽  
pp. 237-242 ◽  
Author(s):  
Mitsunori Shinoda ◽  
Noritake Watanabe ◽  
Takeshi Suko ◽  
Goro Mogi ◽  
Masaharu Takeyama

To clarify the effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) levels in nasal secretions, we employed competitive enzyme-linked immunoassays to measure concentrations of those neuropeptides in nasal secretions from 40 patients with house dust nasal allergy before and after administration of azelastine and oxatomide. One mg of azelastine and 30 mg of oxatomide were administrated twice a day for 4 weeks. Mean values of SP concentrations and ratios of SP to total protein of the nasal allergy group were significantly higher than those of the control group (p < 0.002). The VIP/total protein ratio of the allergy group was also significantly higher than that of the control group, although the VIP concentration alone was not. Mean levels of SP and VIP from patients with severe symptoms were significantly higher than those of the control group (p < 0.05), although those values were not significantly different between patients with moderate symptoms and control subjects. Azelastine and oxatomide effectively reduced SP levels in nasal secretions (p < 0.005), but they did not significantly decrease VIP levels. The reduction of SP levels was significant in patients with excellent responses to those drugs (p < 0.005), but not in patients with poor responses. These findings suggest that SP and VIP levels in nasal secretions may reflect the clinical state of nasal allergy and be one of the better parameters available for evaluating the clinical efficacy of anti-allergic drugs against nasal allergy.


2014 ◽  
pp. 4023-4032 ◽  
Author(s):  
Kerem Ural ◽  
Nuran Aysul ◽  
Huseyin Voyvoda ◽  
Bulent Ulutas ◽  
Osman S. Aldemir ◽  
...  

ABSTRACTObjective. The purposes of this study were to determine whether secnidazole administered at a single dose of 10 mg/kg, orally, lessens or eliminates Giardia cyst shedding, and to validate the benefit of secnidazole treatment on clinical signs and faecal consistency in lambs naturally infected with Giardia duodenalis. Materials and methods. To this extent weaned 12 weeks of age lambs were selected and randomly assigned into two groups based on placebo (group C, n=7 untreated control group) or treatment (group S, n=10 lambs treated with a single dose of secnidazole at 10 mg/kg). Results. On days 0 and 10, before and after treatment, respectively, reduction in cyst excretion was determined. The faecal consistency and general health were recorded at each sampling day. Conclusions. During the study there was a high (99.98%) reduction in cyst excretion in the secnidazol treatment group compared to the positive control group on day 10, resulting in a significant (p<0.001) reduction, making secnidazole highly effective treatment option.


2020 ◽  
Vol 12 (3) ◽  
pp. 234-240
Author(s):  
I. Valchev ◽  
К. Stojanchev ◽  
N. Nicolov ◽  
R. Binev

Abstarct. The aim of the present investigation was to evaluate the effects of aflatoxin B1 and Mycotox NG applied either independently or together, on blood total protein, albumin, blood glucose, total bilirubin, triglycerides, cholesterol, enzyme activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AP), gamma-glutamyl transferase (γ GT), lactate dehydrogenase (LDH) and changes in liver morphology. At the same time, the potential of supplementation of feed with a mycosorbent (Mycotox NG) was evaluated. Experiments were carried out with 40 1-day-old Toulouse geese from mixed sexes divided into one control and three treatment groups (n=10). Groups were as followed: Group I – control (0 mg/kg AFB1 not supplemented with Mycotox NG); Group II (0.5 g/kg Mycotox NG), Group III (0.5 mg/kg AFB1) and Group IV (0.5 mg/kg AFB1 and 0.5 g/kg Mycotox NG). In this study, commercially available geese of Toulouse strain were reared from day one to forty two days in the deep litter system of management and the birds were divided into four groups. Normal feed tested free of aflatoxin (AFB1), was given to the control (Group – 1). 0.5 g/kg Mycotox was supplemented with the feed to Group 2, Aflatoxin (0.5 mg/kg feed) was supplemented with the feed to Group 3 and Mycotox Ng (0.5 g/kg feed) + 0.5 mg/kg feed AFB1 was supplemented with the feed to Group 4. The duration of the experiments was 42 days. The monitored blood chemical parameters were analysed on post treatment days 21 and 42. In birds treated only with AFB1, (group III) increased blood activities of studied enzymes. At the same time, blood total protein, albumin, cholesterol, glucose and triglycerides were reduced as compared to controls. The observed histopathological changes in the liver consisted in various extent of dystrophy (congestion, vacuolar and granular dystrophy, round cell proliferation, necrobiotic changes, hyperplasia of gallbladder epithelium). The addition of mycosorbent (Mycotox NG) to the feed of Groups IV reduced substantially the changes in blood chemistry and the severity and frequency of liver histological lesions. The addition of mycosorbent (Mycotox NG) to the feed of Groups IV reduced substantially the changes in blood chemistry and the severity and frequency of liver histological lesions.


2019 ◽  
Vol 1 (1) ◽  
pp. 017-025
Author(s):  
Abdel Maksoud Hussein ◽  
Omnia Mahmoud ◽  
Mahmoud Khalifa

The aim of this study was to evaluate the immunopotentiating effect of IAD in broiler chickens either vaccinated or unvaccinated and to evaluate the safety profile of IAD after treatment with escalating doses. To assess the immunological effect of IAD, eighty chicks were used and divided into four groups. First group kept as control group, second received Isoprinosine (16.3 mg/kg, day after day), third received a routine New Castle disease virus vaccine and the last group received both treatments of Isoprinosine and ND vaccine. The second part of the study aimed to evaluate the safety profile of IAD, to achieve this aim eighty chicks were used, divided equally and given different concentration of IAD 8.15, 16.3, 32.6 mg/kg day after day repetitively. We concluded that, IAD enhanced both nonspecific and specific immune responses in broiler chicken, especially in vaccinated ones, in terms of increased antibody and decreased NDV titers, indicated by HI and PCR, respectively. Also, IAD showed dose-dependent good safety profile, including blood picture, organ function profile and metabolic parameters, indicated by biochemical analyses.


Sign in / Sign up

Export Citation Format

Share Document